Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1

Iha Park1, Hava Karsenty Avraham

  • 1Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 4 Blackfan Circle, 3rd Floor, Boston, MA 02115, USA.

Insights

ICRF-193, a topoisomerase II inhibitor, triggers DNA damage signaling and cell cycle arrest. This DNA damage response is cell cycle-dependent, highlighting topoisomerase II

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Topoisomerase II is crucial for cell proliferation and survival.
  • It is a validated target for anticancer drug development.
  • ICRF-193 is a known catalytic inhibitor used to study topoisomerase II function.

Purpose of the Study:

  • To investigate the effects of ICRF-193 on DNA damage signaling.
  • To determine the cell cycle dependency of ICRF-193-induced DNA damage.
  • To elucidate the signaling pathways involved in the response to ICRF-193.

Main Methods:

  • Treatment of cells with ICRF-193.
  • Analysis of DNA damage markers (gamma-H2AX, 53BP1, NBS1, BRCA1, MDC1, FANCD2 foci, comet assay).
  • Cell cycle analysis and assessment of signaling pathway activation (ATM, ATR, CHK2, BRCA1 phosphorylation).

Main Results:

  • ICRF-193 treatment induced G2 arrest and significant DNA damage signaling.
  • Formation of multiple DNA damage foci (gamma-H2AX, 53BP1, NBS1, BRCA1, MDC1, FANCD2) and increased comet tail moment confirmed DNA damage.
  • ATM and ATR mediated the DNA damage signaling, which was cell cycle-dependent (S, G2, M, early/late G1 phases).

Conclusions:

  • ICRF-193 induces DNA damage signaling in a cell cycle-dependent manner.
  • Topoisomerase II activity is essential for cell cycle progression, including DNA decondensation.
  • These findings provide insights into the mechanism of action of topoisomerase II inhibitors.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.